 Salvage Therapy
"Salvage Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient's condition. Salvage therapy is most often used for neoplastic diseases.
| Descriptor ID |
D016879
|
| MeSH Number(s) |
E02.895
|
| Concept/Terms |
Salvage Therapy- Salvage Therapy
- Salvage Treatment
- Salvage Treatments
- Treatment, Salvage
- Treatments, Salvage
- Therapy, Salvage
- Salvage Therapies
- Therapies, Salvage
|
Below are MeSH descriptors whose meaning is more general than "Salvage Therapy".
Below are MeSH descriptors whose meaning is more specific than "Salvage Therapy".
This graph shows the total number of publications written about "Salvage Therapy" by people in this website by year, and whether "Salvage Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 | | 2000 | 1 | 2 | 3 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 2 | 2 | | 2004 | 0 | 2 | 2 | | 2005 | 2 | 0 | 2 | | 2006 | 1 | 1 | 2 | | 2007 | 8 | 1 | 9 | | 2009 | 1 | 4 | 5 | | 2010 | 3 | 4 | 7 | | 2011 | 4 | 2 | 6 | | 2012 | 2 | 0 | 2 | | 2013 | 2 | 0 | 2 | | 2014 | 3 | 0 | 3 | | 2015 | 4 | 4 | 8 | | 2016 | 2 | 6 | 8 | | 2017 | 6 | 7 | 13 | | 2018 | 7 | 4 | 11 | | 2019 | 4 | 6 | 10 | | 2020 | 2 | 4 | 6 | | 2021 | 1 | 3 | 4 | | 2022 | 1 | 1 | 2 | | 2023 | 0 | 3 | 3 | | 2024 | 4 | 4 | 8 | | 2025 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Salvage Therapy" by people in Profiles.
-
Hilty Chu BK, Dhimal T, Boyer M, Loria A, Lai SH, Cai X, Li Y, Cupertino P, George V, Aquina CT, Donahue C, Vogel JD, Fleming FJ. A Clinical Primer for Defining Time Zero in Rectal Cancer Studies of Nonoperative Management: Implications for Survival and Local Regrowth. Ann Surg Oncol. 2026 Mar; 33(3):1927-1934.
-
Hess B, Moskowitz A, Davis JA, Strati P, Sawalha Y, Bakos J, Sorrell M, Ferreira AC, Escribano-Serrat S, De Castro M, Brooks TR, Hill BT, Shah GL, Falade AS, Merryman R, Kamdar M, Ip A, Nachar V, Bennett JG, Lux N, Ahmed N, Hoffmann M, LaCasce A. Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-R. Haematologica. 2026 Apr 01; 111(4):1389-1395.
-
Groisser A, Frantz A, Geller JI, Ortiz MV, Walterhouse D, Ranalli M, Woods-Swafford W, Schoettler P, Garrington T, Mullen EA, Ash S, Bardhan P, Balis F, Dome JS. Anti-Tumor Activity of Paclitaxel-Containing Regimens in Recurrent/Refractory Wilms Tumor. Pediatr Blood Cancer. 2025 Oct; 72(10):e31915.
-
Lai SH, Widmar M, Monson JRT, Fleming FJ, Morris AM, Vogel JD. Rectal Cancer Watch-and-Wait Management: Experience of 545 Patients From the US Rectal Cancer Research Group. Dis Colon Rectum. 2025 Feb 01; 68(2):180-189.
-
Berg SA, La Rosa S, Zhang T, Pierorazio PM, Albiges L, Beckermann KE, Campbell MT, Carlo MI, Coleman K, George DJ, Geynisman DM, Johnson R, Jonasch E, Maranchie JK, McGregor BA, Shapiro DD, Singer EA, Shuch BM, Stadler WM, Tannir NM, Zakharia Y, Vaishampayan UN, Thall PF, Msaouel P. Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting. Urol Oncol. 2025 03; 43(3):135-146.
-
Xiang JJ, Campbell MT, Tu SM, Araujo J, Nieto Y, Lin JK, Xiao L, Shah AY, Wang J. Doxorubicin, Paclitaxel, and Cisplatin (ATP) for Relapsed/Refractory Germ Cell Tumors. Clin Genitourin Cancer. 2024 Dec; 22(6):102242.
-
Philip JL, Saben J, Meram E, Steinberg T, Lauer K, Malamon J, Pomfret E, Nydam T, Foley DP, Pshak T. Renal autotransplant as a definitive treatment for nutcracker syndrome: A multicenter retrospective study. J Vasc Surg Venous Lymphat Disord. 2025 Jan; 13(1):101983.
-
Tun AM, Wang Y, Maliske S, Micallef I, Inwards DJ, Habermann TM, Porrata L, Paludo J, Bisneto JV, Rosenthal A, Kharfan-Dabaja MA, Ansell SM, Nowakowski GS, Farooq U, Johnston PB. Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy. Transplant Cell Ther. 2024 10; 30(10):1001.e1-1001.e12.
-
Tun AM, Wang Y, Maliske S, Micallef I, Inwards DJ, Habermann TM, Porrata L, Paludo J, Bisneto JV, Rosenthal A, Kharfan-Dabaja MA, Ansell SM, Nowakowski GS, Farooq U, Johnston PB. Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy. Haematologica. 2024 07 01; 109(7):2186-2195.
-
Heneghan MB, Belsky JA, Milgrom SA, Forlenza CJ. The pediatric approach to Hodgkin lymphoma. Semin Hematol. 2024 08; 61(4):245-252.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|